Real-World Effectiveness, Economic, and Humanistic Outcomes of Selected Oral Antipsychotics in Patients with Schizophrenia: A Systematic Review Evaluating Global Evidence.
Keyuri AdhikariKhalid M KamalKi Jin JeunDavid A NolfiMohammed Najeeb AshrafChristopher ZackerPublished in: ClinicoEconomics and outcomes research : CEOR (2024)
Our research showcased a significant knowledge gap across OATs spanning the humanistic and behavioral outcomes and medication adherence and switching, suggesting a need for robust evidence generation to help clinicians and payers make informed decisions regarding treatment opportunities and cost-effective strategies for patients with schizophrenia.